| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer.
|
World J Surg
|
2009
|
2.02
|
|
2
|
Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.
|
Hum Pathol
|
2004
|
1.77
|
|
3
|
Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
|
Eur Urol
|
2007
|
1.56
|
|
4
|
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
|
Breast Cancer Res Treat
|
2011
|
1.55
|
|
5
|
Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.
|
J Neurooncol
|
2008
|
1.28
|
|
6
|
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients.
|
Breast Cancer Res Treat
|
2006
|
1.25
|
|
7
|
Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells.
|
Cancer Sci
|
2012
|
1.10
|
|
8
|
Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy.
|
Med Oncol
|
2008
|
1.05
|
|
9
|
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group.
|
Breast Cancer Res Treat
|
2009
|
1.05
|
|
10
|
Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer.
|
Int J Clin Oncol
|
2009
|
1.03
|
|
11
|
The notorious "drug lag" for oncology drugs in Japan.
|
Invest New Drugs
|
2011
|
0.95
|
|
12
|
A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer.
|
Gynecol Oncol
|
2012
|
0.94
|
|
13
|
Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells.
|
Free Radic Res
|
2011
|
0.94
|
|
14
|
Efficacy of taxane regimens in patients with metastatic angiosarcoma.
|
Eur J Dermatol
|
2011
|
0.94
|
|
15
|
An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients.
|
Jpn J Clin Oncol
|
2006
|
0.93
|
|
16
|
Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma.
|
J Orthop Sci
|
2010
|
0.93
|
|
17
|
Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.
|
Oncologist
|
2009
|
0.92
|
|
18
|
Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients.
|
Breast J
|
2005
|
0.92
|
|
19
|
Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer.
|
Jpn J Clin Oncol
|
2007
|
0.90
|
|
20
|
Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy.
|
J Cancer Res Clin Oncol
|
2012
|
0.90
|
|
21
|
[Pulmonary tumor thrombotic microangiopathy responding to chemotherapy].
|
Nihon Kokyuki Gakkai Zasshi
|
2011
|
0.88
|
|
22
|
Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation.
|
J Mol Histol
|
2012
|
0.88
|
|
23
|
Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma.
|
Invest New Drugs
|
2014
|
0.87
|
|
24
|
Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma.
|
Oncol Rep
|
2008
|
0.86
|
|
25
|
Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.
|
Jpn J Clin Oncol
|
2003
|
0.86
|
|
26
|
Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer.
|
Breast Cancer Res Treat
|
2005
|
0.85
|
|
27
|
21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.
|
Breast
|
2009
|
0.85
|
|
28
|
Immunohistochemical profile for unknown primary adenocarcinoma.
|
PLoS One
|
2012
|
0.84
|
|
29
|
Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journal.
|
PLoS One
|
2012
|
0.84
|
|
30
|
Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.
|
Jpn J Clin Oncol
|
2009
|
0.83
|
|
31
|
Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.
|
J Surg Oncol
|
2010
|
0.83
|
|
32
|
Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma.
|
Eur J Obstet Gynecol Reprod Biol
|
2011
|
0.83
|
|
33
|
Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis.
|
Jpn J Clin Oncol
|
2010
|
0.83
|
|
34
|
Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer.
|
Int J Clin Oncol
|
2011
|
0.83
|
|
35
|
Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy.
|
Cancer Chemother Pharmacol
|
2010
|
0.83
|
|
36
|
Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.
|
Int J Clin Oncol
|
2013
|
0.83
|
|
37
|
Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
|
Ann Surg Oncol
|
2011
|
0.82
|
|
38
|
Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel.
|
Int J Clin Oncol
|
2003
|
0.82
|
|
39
|
Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.
|
Jpn J Clin Oncol
|
2009
|
0.82
|
|
40
|
Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.
|
J Cancer Res Clin Oncol
|
2008
|
0.81
|
|
41
|
Feasibility and usefulness of the 'Distress Screening Program in Ambulatory Care' in clinical oncology practice.
|
Psychooncology
|
2010
|
0.81
|
|
42
|
Clinical efficacy of S-1 in pretreated metastatic breast cancer patients.
|
Jpn J Clin Oncol
|
2008
|
0.81
|
|
43
|
Expression of BMP-2 and Ets1 in BMP-2-stimulated mouse pre-osteoblast differentiation is regulated by microRNA-370.
|
FEBS Lett
|
2012
|
0.81
|
|
44
|
The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.
|
Support Care Cancer
|
2006
|
0.81
|
|
45
|
Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy.
|
Breast
|
2007
|
0.80
|
|
46
|
Regulation of the differentiation of osteoblasts and osteoclasts by a hot-water extract of adzuki beans (Vigna angularis).
|
Biosci Biotechnol Biochem
|
2014
|
0.80
|
|
47
|
Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer.
|
Am J Clin Oncol
|
2010
|
0.80
|
|
48
|
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome.
|
Breast Cancer Res Treat
|
2008
|
0.80
|
|
49
|
Primary yolk sac tumor of the omentum: a case report and literature review.
|
Case Rep Oncol
|
2012
|
0.79
|
|
50
|
Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population.
|
J Cancer Res Clin Oncol
|
2007
|
0.79
|
|
51
|
Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer.
|
Jpn J Clin Oncol
|
2008
|
0.79
|
|
52
|
Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
|
Pathol Res Pract
|
2006
|
0.78
|
|
53
|
Immunomodulatory effects of heat-killed Enterococcus faecalis TH10 on murine macrophage cells.
|
Microbiologyopen
|
2012
|
0.78
|
|
54
|
A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer.
|
Cancer Chemother Pharmacol
|
2013
|
0.78
|
|
55
|
Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society.
|
Jpn J Clin Oncol
|
2008
|
0.78
|
|
56
|
Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
|
J Cancer Res Clin Oncol
|
2008
|
0.78
|
|
57
|
Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.
|
Cancer Chemother Pharmacol
|
2012
|
0.77
|
|
58
|
[Survey on oncologists-provided information on treatment-related infertility to breast cancer patients].
|
Gan To Kagaku Ryoho
|
2012
|
0.77
|
|
59
|
Reduced scytonemin isolated from Nostoc commune induces autophagic cell death in human T-lymphoid cell line Jurkat cells.
|
Food Chem Toxicol
|
2013
|
0.77
|
|
60
|
Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy.
|
Breast
|
2013
|
0.77
|
|
61
|
Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan.
|
Int J Clin Oncol
|
2006
|
0.77
|
|
62
|
Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.
|
Clin Breast Cancer
|
2011
|
0.76
|
|
63
|
Hot water extract of adzuki (Vigna angularis) suppresses antigen-stimulated degranulation in rat basophilic leukemia RBL-2H3 cells and passive cutaneous anaphylaxis reaction in mice.
|
Phytother Res
|
2011
|
0.76
|
|
64
|
Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy.
|
Breast Cancer Res Treat
|
2006
|
0.76
|
|
65
|
The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery.
|
Ann Surg
|
2004
|
0.76
|
|
66
|
Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
67
|
Second-line chemotherapy in patients with primary unknown cancer.
|
J Cancer Res Clin Oncol
|
2011
|
0.75
|
|
68
|
Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors.
|
Oncology
|
2010
|
0.75
|
|
69
|
A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.
|
Med Oncol
|
2010
|
0.75
|
|
70
|
A synthesized nostocionone derivative potentiates programmed cell death in human T-cell leukemia Jurkat cells through mitochondria via the release of endonuclease G.
|
Nutr Cancer
|
2014
|
0.75
|
|
71
|
Outpatient management of low-risk febrile patients on paclitaxel and carboplatin for ovarian cancer.
|
Int J Gynaecol Obstet
|
2009
|
0.75
|
|
72
|
OM-X®, Fermented Vegetables Extract Suppresses Antigen-Stimulated Degranulation in Rat Basophilic Leukemia RBL-2H3 Cells and Passive Cutaneous Anaphylaxis Reaction in Mice.
|
Nat Prod Commun
|
2015
|
0.75
|
|
73
|
[A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer].
|
Gan To Kagaku Ryoho
|
2006
|
0.75
|
|
74
|
[Current topics of chemotherapy for sarcoma and bone neoplasms].
|
Gan To Kagaku Ryoho
|
2008
|
0.75
|
|
75
|
[VDC (A) + IE alternate chemotherapy].
|
Nihon Rinsho
|
2015
|
0.75
|
|
76
|
Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed.
|
Breast Cancer Res Treat
|
2008
|
0.75
|
|
77
|
The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors.
|
Urol Oncol
|
2010
|
0.75
|
|
78
|
Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate.
|
Int J Clin Oncol
|
2008
|
0.75
|
|
79
|
Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.
|
Oncology
|
2017
|
0.75
|
|
80
|
Whiskey congeners suppress LPS/IFNγ-induced NO production in murine macrophage RAW 264 cells by inducing heme oxygenase-1 expression.
|
J Agric Food Chem
|
2012
|
0.75
|
|
81
|
[Genetic testing for effective Herceptin therapy].
|
Nihon Rinsho
|
2002
|
0.75
|
|
82
|
Structural and ultrastructural changes of full-cycle cultured Pacific bluefin tuna (Thunnus orientalis) muscle slices during chilled storage.
|
J Sci Food Agric
|
2012
|
0.75
|
|
83
|
Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy.
|
J Cancer Res Clin Oncol
|
2006
|
0.75
|
|
84
|
Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection.
|
Oncology
|
2012
|
0.75
|
|
85
|
Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody.
|
Oncology
|
2017
|
0.75
|